Scilex Holding Company (SCLX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $10.06M
Last updated: Nov 17, 2026 at 11:04 AM ET
Scilex Holding Company (SCLX) Financials: Revenue, Profit and Cash Flow
Scilex Holding Company reported revenue of $30.25M for the fiscal year ended Dec 31, 2025, down 46.5% from the year before. That year, net income was -$374.05M with a net margin of -1236.4%, operating cash flow was $3.82M and free cash flow was $2.68M. The quarter ended Jun 30, 2026 had revenue of $7.64M and net income of -$229.97M.
Revenue and Margins
Over the 6 years to Dec 2025, revenue grew from $21.03M, a compound annual rate of 6.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $30.25M | -46.5% | 65.0% | -1143.7% | -1236.4% |
| Dec 2024 | $56.59M | +21.1% | 70.5% | -147.4% | -128.7% |
| Dec 2023 | $46.74M | +22.9% | 66.5% | -225.6% | -244.6% |
| Dec 2022 | $38.03M | +21.4% | 71.6% | -133.1% | -61.4% |
| Dec 2021 | $31.32M | +32.9% | 88.4% | -114.4% | -282.4% |
| Dec 2020 | $23.56M | +12.0% | 90.9% | -149.7% | -201.7% |
| Dec 2019 | $21.03M | N/A | 72.4% | -659.4% | -849.1% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $30.25M | $56.59M | $46.74M | $38.03M | $31.32M | $23.56M | $21.03M |
| Cost of revenue | $10.60M | $16.69M | $15.68M | $10.80M | $3.63M | $2.15M | $5.80M |
| Gross profit | $19.65M | $39.90M | $31.06M | $27.24M | $27.68M | $21.41M | $15.23M |
| Research and development | $20.71M | $9.64M | $12.75M | $9.05M | $9.20M | $9.96M | $85.52M |
| Operating income | -$346.01M | -$83.40M | -$105.43M | -$50.63M | -$35.84M | -$35.26M | -$138.69M |
| Net income | -$374.05M | -$72.81M | -$114.33M | -$23.36M | -$88.42M | -$47.52M | -$178.59M |
| EBITDA | N/A | -$66.48M | N/A | -$35.29M | N/A | -$20.02M | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.64M | $8.61M | $4.79M | $10.56M | $9.90M | $5.00M | $14.90M | $14.44M | $16.37M | $10.88M | $13.46M | $10.12M |
| Gross profit | $3.96M | $4.17M | $2.18M | $7.23M | $6.62M | $3.62M | $10.21M | $10.67M | $11.98M | $7.04M | $8.94M | $6.72M |
| Operating income | -$29.42M | -$32.17M | -$111.09M | -$186.51M | -$20.51M | -$27.90M | -$28.38M | -$19.92M | -$15.62M | -$19.48M | -$18.34M | -$38.80M |
| Net income | -$229.97M | -$45.65M | -$46.10M | -$257.82M | -$88.10M | -$26.08M | -$6.46M | -$4.39M | -$37.58M | -$24.38M | -$21.40M | -$35.53M |
Balance Sheet
As of Dec 2025, total debt of $105.74M exceeded cash and equivalents by $100.79M. Shareholder equity was negative, at -$207.78M, as total liabilities of $576.73M exceeded total assets of $364.98M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $364.98M | $92.95M | $101.31M | $86.53M | $77.93M | $199.48K | N/A |
| Current assets | $38.36M | $41.55M | $46.78M | $29.61M | $23.00M | $30.51K | N/A |
| Cash and equivalents | $4.96M | $3.27M | $3.92M | $2.18M | $4.34M | $30.51K | N/A |
| Total liabilities | $576.73M | $285.59M | $274.25M | $50.29M | $301.81M | $180.76K | N/A |
| Short-term debt | $83.26M | $34.88M | $108.43M | $0 | $57.56M | $125.00K | N/A |
| Long-term debt | $22.48M | $845.00K | $17.04M | $0 | $95.54M | $107.66M | N/A |
| Shareholder equity | -$207.78M | -$192.64M | -$172.94M | $36.24M | -$223.88M | $18.72K | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $253.56M | $293.63M | $364.98M | $275.88M | $83.75M | $78.98M | $92.95M | $100.43M | $104.54M | $91.24M | $101.31M | $80.53M |
| Total liabilities | $564.05M | $547.71M | $576.73M | $455.60M | $332.74M | $290.46M | $285.59M | $311.75M | $319.24M | $281.03M | $274.25M | $243.20M |
| Cash and equivalents | $566.00K | $3.35M | $4.96M | $878.00K | $4.10M | $5.80M | $3.27M | $77.00K | $6.89M | $1.82M | $3.92M | $1.95M |
| Shareholder equity | -$308.32M | -$249.22M | -$207.78M | -$176.94M | -$248.99M | -$211.48M | -$192.64M | -$211.32M | -$214.69M | -$189.79M | -$172.94M | -$162.67M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 70.2% of operating cash flow. Share repurchases came to 1072.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.82M | $19.35M | -$20.71M | -$21.26M | -$28.66M | -$31.46M | -$60.42M |
| Capital expenditures | $1.13M | $0 | $30.00K | $7.00K | $0 | $25.00K | $584.00K |
| Free cash flow | $2.68M | $19.35M | -$20.74M | -$21.27M | -$28.66M | -$31.49M | -$61.01M |
| Dividends paid | N/A | N/A | $10.00M | N/A | N/A | N/A | N/A |
| Share repurchases | $28.75M | $0 | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | $4.08M | -$2.67M | -$330.00K | -$2.07M | $0 | -$25.00K | -$17.62M |
| Financing cash flow | -$5.46M | -$18.13M | $23.58M | $21.17M | $28.16M | -$19.17M | $15.78M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.74M | -$1.11M | -$17.47M | $8.23M | $7.05M | $6.01M | $2.53M | $5.11M | $2.31M | $9.39M | -$5.39M | $5.90M |
| Capital expenditures | N/A | $3.05M | $83.00K | $300.00K | N/A | $150.00K | $150.00K | $150.00K | $150.00K | $150.00K | $1.00K | $21.00K |
| Free cash flow | N/A | -$4.16M | -$17.55M | $7.93M | N/A | $5.86M | $2.38M | $4.96M | $2.16M | $9.24M | -$5.39M | $5.88M |
Frequently Asked Questions About SCLX
What is Scilex Holding Company's annual revenue?
Scilex Holding Company reported revenue of $30.25M for the fiscal year ended Dec 31, 2025.
How fast is Scilex Holding Company's revenue growing?
Revenue was down 46.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -7.3%.
Is Scilex Holding Company profitable?
No. Scilex Holding Company reported net income of -$374.05M for the fiscal year ended Dec 31, 2025, with a net margin of -1236.4%.
How much free cash flow does SCLX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $3.82M minus capital expenditures of $1.13M produced free cash flow of $2.68M.
How much debt does Scilex Holding Company have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $22.48M, short-term debt of $83.26M and cash and equivalents of $4.96M.
SCLX pages: Overview, Earnings, Forecast, Financials, Competitors